NEKTAR THERAPEUTICS — Director's Dealing 2016

Sep 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-09-21

Reporting Person: Lingnau Lutz (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-21	Common Stock	A	8000	$0.00	Acquired	30450	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-21	Stock Option	$19.15	A	20000	Acquired	2024-09-20	Common Stock (20000)	Direct

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit award vests in full, one year following September 21, 2016.

F3: This option vests in equal monthly installments over the one-year period beginning on September 30, 2016.